rTMS for Anxiety: Rewiring the Brain at Its Root · London

There's no single answer that fits everyone, and that's actually important to say, because anxiety can look so different from person to person. That said, NICE guidelines point to CBT as the most well-evidenced talking therapy, and SSRIs or SNRIs as the most commonly recommended medication. For many people, one or both of these make a real difference. But for those who've tried the standard routes and still don't feel better, rTMS is an evidence-supported option worth knowing about. Rather than working at the level of thoughts or brain chemistry alone, it works directly with the neurological circuits that keep anxiety running, which, for some people, is exactly the level where the work needs to happen.

If you'd rather not take medication, or you've tried it and it wasn't right for you, there are genuine options. CBT remains the most researched talking therapy for anxiety, and approaches like ACT, EMDR, and mindfulness-based cognitive therapy can each be valuable depending on what's driving things for you. rTMS sits in a slightly different category. Where most therapies work with how you think, respond, or pay attention, rTMS works directly with the brain circuits involved in anxiety itself. For people who've already done a course of CBT, or who can't tolerate medication, it offers something the others don't: a way of treating anxiety at its neurological root, not just managing it from the outside.

rTMS produces measurable changes in anxiety levels from as early as the 5th–10th session, with significant improvements typically noted within 2–4 weeks of beginning a treatment course. This is faster than the standard 6–12 week response timeline for SSRIs, and faster than a full course of CBT. The speed of response varies by individual and by anxiety subtype: panic disorder and generalised anxiety disorder respond at different rates. At Naya Health, NeuroScore™ monitoring tracks your progress in real time.

High-functioning anxiety is what happens when everything looks fine from the outside: the career, the relationships, the ability to show up and perform. But, on the inside, your mind rarely stops. It's the constant mental activity that won't quiet down. The perfectionism that feels less like a strength and more like a pressure you can't escape. The way your body holds tension, even when nothing is technically wrong. The low-level sense that something bad is coming, even when it isn't. At Naya, we take high-functioning anxiety seriously as a clinical presentation in its own right. Through the NeuroScore™ assessment, we look at what's actually happening in the brain, not just the symptoms on the surface, and use rTMS to work directly with the neurological patterns keeping anxiety in place.

Most patients with anxiety complete an initial course of 10–20 sessions. Sessions are typically delivered daily or on alternate days, meaning the full course can be completed in 2–6 weeks. Early improvements are often noticed from sessions 5–10 onwards. The exact number of sessions required depends on the severity and chronicity of the anxiety, the specific protocol used, and how the individual’s brain responds.

Yes. Treatment-resistant anxiety is one of the presentations most suited to rTMS. The reason is mechanistic: standard treatments address anxiety at the cognitive or neurochemical level, but not directly at the level of the dysfunctional neural circuits generating it. rTMS reaches where other treatments cannot. Clinical evidence for rTMS in treatment-resistant anxiety is growing, particularly for generalised anxiety disorder and panic disorder.

At Naya Health, anxiety treatment involves rTMS sessions rather than talking therapy (though it can complement ongoing therapy). Sessions last 30 minutes. You sit in a reclining chair while a clinician positions a TMS coil on your scalp, delivering magnetic pulses felt as a gentle tapping. You stay fully awake and can read or relax. There’s no anaesthesia, recovery time, or disruption afterward. Before starting, your NeuroScore™ assessment is reviewed and your personalised protocol explained.

rTMS for anxiety is not currently available on the NHS. NHS provision of rTMS is primarily limited to treatment-resistant depression in specialist settings. Waiting times for NHS psychological therapy (IAPT/Talking Therapies) for anxiety disorders can be many months. For patients who require faster access, have not found adequate relief through NHS-available treatments, or want a neurological treatment not currently available through public health channels, Naya Health provides private rTMS for anxiety in London.

Yes. Many Naya patients seek treatment because medication hasn’t helped or isn’t suitable long-term. rTMS works differently, directly modulating neural circuits rather than altering neurotransmitters, so non-responders to medication may still benefit. Early data at Naya show over 90% of patients experience meaningful improvement across conditions, including anxiety, depression, pain, and fatigue, though individual results vary and outcomes aren’t guaranteed.

CBT (cognitive behavioural therapy) is the most extensively evidenced psychological treatment for anxiety disorders and produces meaningful improvement in approximately 50–60% of patients who complete a full course. It works by helping patients identify and challenge the thought patterns that trigger and sustain anxiety. For the 40–50% of patients who do not achieve sufficient improvement with CBT, or who relapse after an initial response, rTMS offers a complementary neurological approach. Unlike CBT, rTMS targets the neural circuitry driving the anxiety rather than the cognitive content it produces. The two approaches work at different levels and are fully compatible.

Anxiety is the leading cause of reduced performance, presenteeism, and avoidance behaviour in professional settings. High-functioning anxiety, which is particularly common among executives, lawyers, clinicians, and other high-demand roles, creates significant cognitive overhead: the mental bandwidth consumed by constant worry, over-checking, and threat-scanning directly reduces the capacity available for creative thinking, decision-making, and presence with others. rTMS addresses this by reducing the neurological activity driving the anxious vigilance, not by dulling performance, but by removing the noise that is crowding it out.

They can feel completely different to live with, but they share more in common than most people realise. Anxiety disorder (especially GAD) involves a chronic, diffuse state of worry and tension, a persistent sense of threat not tied to specific triggers. Panic disorder, by contrast, involves sudden episodes of intense fear with physical symptoms like a racing heart, breathlessness, dizziness, and a sense of losing control. Both share amygdala hyperactivity and reduced prefrontal regulation, and often co-occur. rTMS can treat both, with protocols tailored to the dominant presentation, guided by Naya’s clinical assessment.